Lakeshore Cancer Center

Name

Lakeshore Cancer Center

Legal name

Lakeshore Cancer Center

Website

https://lakeshorecancercenter.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Oncology Services / Cancer Care

NAICS

Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology services
• Cancer screening
• Cancer treatment
• Chemotherapy immunotherapy
• Palliative care

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Services Revenue: Direct healthcare service fees from cancer screening, diagnosis, treatment (chemotherapy, immunotherapy), palliative care, and consultation services across multiple facilities
2. Corporate Screening Packages: Cancer screening packages offered to families and corporate organizations at discounted rates, including various lab tests and imaging such as mammograms and ultrasound

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Lakeshore Cancer Center provides comprehensive cancer prevention and treatment services through three hospital facilities in Nigeria, spanning screening (breast, prostate, cervical, colon), diagnostics, chemotherapy, immunotherapy, palliative care, and survivorship support. The center follows NCCN international treatment guidelines and provides tele-medicine access to international cancer experts through its affiliation with Roswell Park Cancer Institute. It also operates complementary programs including the Dewdrops Support Group, weekly Tumor Board, Foundation for Cancer Care, and a clinical research program.

Product overview

Lakeshore Cancer Center is Nigeria's first operational facility solely dedicated to cancer prevention and treatment, operating as a multi-location healthcare provider with three facilities in Victoria Island (Lagos), Ikeja (Lagos), and Port Harcourt. The center offers an integrated portfolio of oncology services centered on a four-pillar model: Cancer Screening (covering breast, prostate, cervical, and colon cancers), Diagnostic Services (lab testing, imaging, genetic tests, biopsies), Treatment and Consultation (chemotherapy, immunotherapy, palliative care, tele-medicine access to international experts), and Survivorship Support (Dewdrops Support Group, tumor board reviews). The center also operates subsidiary programs including the Foundation for Cancer Care non-profit organization, Learn with Lakeshore educational platform, and clinical research initiatives including the Cost-FIN financial navigation study. With strong affiliations to Roswell Park Cancer Institute, the center provides second opinion consultations and access to an extensive referral network for radiotherapy services within and outside Nigeria.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Screening Comprehensive cancer screening services covering the four preventable cancers (breast, prostate, cervical, and colon), offered to individuals, families, and corporate organizations through packages that include various lab tests and imaging such as mammograms and ultrasound.
• Diagnostic Services State-of-the-art diagnostic facilities providing lab testing, diagnostic imaging, endoscopic examinations, genetic tests, tumor biopsies, and precision detection for early-stage cancer identification.
• Treatment, Consultation and Planning Comprehensive treatment services including chemotherapy, immunotherapy following NCCN guidelines, second opinion consultations with international colleagues, oncology nursing care, nutritional support, physiotherapy, psychological support, palliative care, and pain management.
• Telemedicine Services Access to an extensive pool of international cancer experts via periodic short-tenure visits at the center and tele-medicine consultations for second opinions and collaborative care.
• Lakeshore Tumor Board Active weekly tumor board drawing from a range of clinical expertise for multidisciplinary case review, training, education, and clinical care oversight for cancer patients.
• Dewdrops Support Group Cancer survivorship and support group providing emotional support, education, nutrition and lifestyle coaching, and advocacy for cancer patients, survivors, and caregivers.
• Cost-FIN Research Program Research study evaluating the impact of financial navigation programs for patients diagnosed with breast, colorectal, or prostate cancer, providing free financial navigation services to eligible participants.
• Patient Referral Services Referral system enabling healthcare providers to schedule appointments for patients with their clinical information and referring doctor details, channeling patients to the appropriate service at Lakeshore Cancer Center.
• Clinical Trials Program Research programs including clinical trials conducted at the center and in collaboration with affiliated academic institutions to expand oncology treatment options for patients.

Quantifiable outcome

• Over 60 peer-reviewed publications in oncology

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Foundation for Cancer Care in West Africa (FCCWA)coreStrategic or Co-development Partner · 1 January 2008Registered non-profit organization established in 2008 to enhance cancer care in West Africa. Founded by individuals interested in fostering collaborative cancer control and prevention throughout the West African sub-region. Core objectives include establishing partnerships between oncology professionals, private enterprise, and academic institutions.
• Roswell Park Cancer Institute (RPCI)coreStrategic or Co-development PartnerStrong ties to the oldest cancer center in the world located in Buffalo, New York. Provides access to international cancer experts through periodic short tenure at Lakeshore Cancer Center and tele-medicine consultations. Enables second opinion consultations and collaborative clinical oversight.
• Northwestern UniversityminorStrategic or Co-development PartnerResearch partnership for Cost-FIN study evaluating financial navigation impact on cancer patients. Dr. Juliet Lumati from Northwestern serves as principal investigator. Study assesses efficacy of financial navigation program for breast, colorectal, and prostate cancer patients.
• OAUTHC (Obafemi Awolowo University Teaching Hospital)minorStrategic or Co-development PartnerClinical research partnership for Cost-FIN study participant enrollment. OAUTHC participant enrollment contact: +234 705 406 5163.
• Learn with LakeshoreminorStrategic or Co-development PartnerEducational platform partner for training and professional development in oncology.
• Macmillan Cancer Support (UK)minorStrategic or Co-development PartnerCynthia Ikejiani, Nursing Administrator, received specialized training from Macmillan Cancer Support in patient communication and survivorship support.
• British Nigerian Oncology Group (BNOG)minorStrategic or Co-development PartnerDr. Chinenye Iwuji is founding member and current President of BNOG, providing networks for research opportunities and clinical trials.
• Carib HealthminorStrategic or Co-development PartnerMr. Babatunde Soteye from Carib Health conducted nutrition and diet session for cancer survivors at Dewdrops Support Group event.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Marcelle Ruth Cancer Centre & Specialist Hospital: Private specialty oncology center also operating in Lagos, Nigeria, offering multidisciplinary cancer screening, diagnostics, and treatment. Directly comparable in geography, customer base, and outpatient oncology service mix to Lakeshore Cancer Center.
• Roswell Park Comprehensive Cancer Center: Designated NCI comprehensive cancer center in Buffalo, NY, and Lakeshore's named collaboration partner. Directly comparable on oncology-only specialty care model, multidisciplinary tumor board, and research portfolio, though materially larger and US-based.
• HCG (HealthCare Global Enterprises): India's largest specialty oncology chain running multi-city cancer hospitals with medical oncology, radiation therapy, and corporate screening. Highly comparable emerging-market specialty oncology replication model to LCC's planned multi-city build-out.
• Tata Memorial Hospital: India's flagship public specialty cancer hospital, an emerging-market benchmark for high-volume, multidisciplinary oncology care with active research and screening programs. Comparable as a specialty-cancer model serving an underserved population.

Broad incumbents

• MD Anderson Cancer Center: Global bellwether for academic specialty cancer care, with standards (NCCN) that LCC explicitly aligns to. Comparable as a comprehensive oncology provider; serves as the broader reference point for clinical credibility.
• Memorial Sloan Kettering Cancer Center: US specialty cancer leader providing multidisciplinary oncology, clinical trials, and survivorship programs. Comparable on integrated screening-to-survivorship model that LCC mirrors, though at vastly larger scale.
• American Oncology Network: US physician-led community oncology network aggregating medical oncology practices. Comparable as a multi-site outpatient oncology operator with corporate/managed-care contracts.

Regional players

• National Hospital Abuja – National Cancer Centre: Major Nigerian tertiary hospital with oncology services in Abuja. Comparable as another Nigerian oncology provider serving similar patient base but publicly funded and not a direct private competitor to LCC's Lagos base.
• Acibadem Healthcare Group – Oncology: Private Turkish hospital group with comprehensive oncology programs across multiple cities. Comparable as an emerging-market, multi-site private specialty oncology operator, though operating in a different geography.

Others

• City Cancer Challenge (C/Can): City-level initiative supporting cities in LMICs to design and deliver cancer care solutions. Comparable ecosystem player addressing the same problem LCC tackles, and a potential collaboration/donor counterpart.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@lcccares
• Facebookfacebook.com/lakeshorecancercenter
• LinkedInlinkedin.com/company/lakeshore-cancer-center
• Instagraminstagram.com/lcccares
• Xx.com/lakeshorecancer

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lakeshore Cancer Center